STERIS plc

STERIS plc FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of STERIS plc (STE) as of Oct 11, 2026 is 123.86 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 126.58 % — a change of -2.15% (lower).

FCF Conversion

123.86 %

YoY

-2.15%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of STERIS plc is 2026 123.86 % . FCF Conversion Rate (FCF/EBITDA) of STERIS plc was 2025 126.58 % . It decreases by -2.15% lower compared to the previous year.

The STERIS plc FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2019
115.04 USD
Jan 1, 2020
92.24 USD
Jan 1, 2021
113.33 USD
Jan 1, 2022
162.88 USD
Jan 1, 2023
369.03 USD
Jan 1, 2024
162.05 USD
Jan 1, 2025
126.58 USD
Jan 1, 2026
123.86 USD
The STERIS plc FCF Conversion history
YEARFCF ConversionYoY
123.86 %-2.15%
126.58 %-21.89%
162.05 %-56.09%
369.03 %+126.57%
162.88 %+43.72%
113.33 %+22.86%
92.24 %-19.82%
115.04 %+14.55%
100.43 %-56.03%
228.42 %+97.25%
115.80 %-2.72%
119.04 %+25.01%
95.23 %—
Access this data via the Eulerpool API

STERIS plc Stock analysis

What does STERIS plc do? Steris plc is a global provider of products and services in the field of sterilization and disinfection. The company was founded in the United States in 1985 and became an Irish company with headquarters in Dublin in 2015. Steris plc's business model is based on offering solutions for the sterilization and disinfection of medical devices, rooms, and instruments. The company offers a wide range of products and services, including machines and equipment, chemicals and consumables, as well as consulting and training services. Steris plc is divided into several business segments, each focused on specific customer needs. The Healthcare Products division provides solutions for hospitals and medical facilities, including cleaning and disinfecting agents, surgical instruments, and sterilization equipment. The Life Sciences division offers products and services for biotechnology, pharmaceutical, and medical device companies, such as cleaning and sterilization services that comply with FDA regulations. Another important area of Steris plc is Applied Sterilization Technologies, which offers customized solutions for customers in various industries. These range from sterilizing food and beverages to industrial applications such as sterilizing materials in the automotive industry. In addition to offering products and services, Steris plc also specializes in consulting and training for customers. The company provides a wide range of training and seminars to ensure optimal use of sterilization and disinfection products and maximize safety and efficiency. One of Steris plc's most well-known products is the "STERIS V-PRO" system. This system is an automated sterilizer that allows for rapid sterilization of medical instruments and devices. Unlike traditional sterilization methods, this system uses high-energy waves for sterilization, making it possible to sterilize sensitive instruments and materials that may not be possible with conventional methods. Another product of Steris plc is the "SYSTEM 1" sterilization process, used for the sterilization of flexible endoscopes. This process is particularly efficient and effective, sterilizing the endoscopes quickly and thoroughly without causing damage during the process. Steris plc is a pioneer in the field of sterilization and disinfection and has established itself as a leading provider in this field. The company aims to develop innovative solutions to help customers worldwide meet their sterilization and disinfection requirements optimally. STERIS plc is one of the most popular companies on Eulerpool.

Frequently Asked Questions about STERIS plc stock

FCF Conversion Rate (FCF/EBITDA) of STERIS plc is 123.86 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of STERIS plc changed from 126.58 % to 123.86 %, representing a -2.15% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) STERIS plc since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s STERIS plc with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

Cash Flow — STERIS plc

All Key Metrics — STERIS plc